John Overdeck’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$178K Sell
224,537
-255,200
-53% -$182K ﹤0.01% 4814
2026
Q1
$220K Sell
479,737
-1,360,399
-74% -$1.25M ﹤0.01% 4247
2025
Q4
$4.05M Buy
+1,840,136
New +$2.96M 0.01% 1903

Other funds holding GUTS

John Overdeck's GUTS Position: Q2 2026 in Review

John Overdeck reduced its Fractyl Health (GUTS) stake by 53% in Q2 2026, selling an estimated $182K and leaving 224,537 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #4814.

John Overdeck first reported a position in GUTS in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.05M in Q4 2025. 76 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • John Overdeck held 224,537 shares of Fractyl Health worth $178K as of Q2 2026.
  • John Overdeck sold 255,200 Fractyl Health shares in Q2 2026, an estimated $182K.
  • Fractyl Health made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4814 holding.
  • John Overdeck first reported a position in Fractyl Health in Q4 2025 and has held it in 3 quarters since.
  • John Overdeck's Fractyl Health position peaked at $4.05M in Q4 2025.
  • 76 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.